Fundraising Fox
/Companies
Sign in

Navitor Pharmaceuticals

Cambridge, US · Founded 2010 · Delaware corporation · 7 employees on LinkedIn · 6 known investors

Find your way into Navitor Pharmaceuticals

Biotech

Founders & leadership

RL
Rick LundbergExecutive
GPGeorge P. Vlasuk
George P. VlasukTechnical Consultant

Board

JFJean-Francois Formela
Jean-Francois FormelaBoard directorPartner at Atlas Venture
ACAlan Crane
Alan CraneBoard directorEntrepreneur Partner at Polaris Partners
MNMarian Nakada
Marian NakadaBoard Member2013–2025Vice President, Venture Investments at JJDC
BGBrian Gallagher
Brian GallagherBoard of Directors2014–2018Partner at SR One Capital Management
VP
Vinzenz PloererBoard director
DM
David MaddenBoard director
PF
Paul FriedmanBoard director
BB
Barry BurgdorfBoard director

Investors · 6

Brace Pharmalisted by Brace PharmaAtlanta

How we know: Brace Pharma's portfolio page · Not right? Tell us

Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M

How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Atlas VenturereportedCambridge · $500K – $1Mvia Kevin Bitterman · board

How we know: board seat on SEC Form D · funding news · Not right? Tell us

Polaris PartnersreportedBoston · $500K – $5Mvia Alan Crane · board

How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

SR One Capital ManagementinferredRedwood Cityvia Rajeev Dadoo · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$68.2M disclosed across 5 rounds · 2013–2020

▶$20.2MraisedMay 2020 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rajeev DadooDirector
  • David MaddenDirector
  • Georg VlasukDirector
  • Kevin BittermanDirector
  • John CreecyExecutive Officer, Director
  • Marian NakadaDirector
  • Vinzenz PloererDirector
  • Alan CraneDirector
  • Richard LundbergExecutive Officer
  • Thomas HughesExecutive Officer
Offering amount
$20.2M
Amount sold
$20.2M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.3MraisedJan 2019 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Alan CraneDirector
  • David MaddenDirector
  • George P. VlasukExecutive Officer, Director
  • Rick LundbergExecutive Officer
  • Kevin BittermanDirector
  • Rajeev DadooDirector
  • Marian Nakada, Ph.D.Director
  • Thomas HughesExecutive Officer, Director
  • Vinzenz PloererDirector
  • John CreecyDirector
Offering amount
$11.3M
Amount sold
$11.3M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.3MraisedMar 2018 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • George P. VlasukExecutive Officer, Director
  • Vinzenz PloererDirector
  • John CreecyDirector
  • David MaddenDirector
  • Alan CraneDirector
  • Brian Gallagher, Ph.D.Director
  • Rick LundbergExecutive Officer
  • Paul Friedman, M.D.Director
  • Marian Nakada, Ph.D.Director
  • Kevin BittermanDirector
Offering amount
$25M
Amount sold
$11.3M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedDec 2015 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jean-Francois FormelaDirector
  • Rick LundbergExecutive Officer
  • Alan CraneDirector
  • David MaddenDirector
  • Marian NakadaDirector
  • Brian GallagherDirector
  • Paul FriedmanDirector
  • George P. VlasukExecutive Officer, Director
  • Barry BurgdorfDirector
  • Vinzenz PloererDirector
Offering amount
$33.3M
Amount sold
$12M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.5MraisedAug 2014 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rick LundbergExecutive Officer
  • George VlasukExecutive Officer, Director
  • Brian GallagherDirector
  • Alan CraneDirector
  • Marian NakadaDirector
  • Jean-Francois FormelaDirector
Offering amount
$23.5M
Amount sold
$13.5M
First sale
Sep 2013
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Navitor Pharmaceuticals went on to found or lead other companies.

Alan CraneDirectorFounded Seismic Therapeutic +1Jean-François FormelaDirectorFounded Korro BioKevin BittermanBoard of DirectorsFounded Editas MedicineEddine SaiahPromoted several times to ultimately Chief Scientific OfficerFounded Stablix

Frequently asked questions

Who are Navitor Pharmaceuticals's investors?
Navitor Pharmaceuticals's investors include age1, Brace Pharma, Sanofi Ventures, Atlas Venture, Polaris Partners, SR One Capital Management.
How much funding has Navitor Pharmaceuticals raised?
Navitor Pharmaceuticals has disclosed $68.2M raised across 5 rounds.
Where is Navitor Pharmaceuticals headquartered?
Navitor Pharmaceuticals is headquartered in Cambridge, US.